A dataset for mapping the Japanese drugs to RxNorm standard concepts

Observational Health Data Sciences and Informatics (OHDSI) is an international research community dedicated to large-scale observational studies using real-world healthcare data. Participation in OHDSI requires mapping local terminology systems to the OHDSI Standard Vocabulary (OSV) and transforming healthcare data into the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM), a standardized database schema. Adherence to the OSV and CDM enables the integration of datasets from different countries and regions, facilitating international cross-sectional analyses and supporting the discovery of large-scale evidence and new medical knowledge. Despite the globally recognized healthcare technology and systems excellence in Japan, Japanese real-world data (RWD) remain underutilized in international research. This is primarily due to reliance on domestically managed controlled terminologies in Japan that are not aligned with international controlled terminologies such as SNOMED CT, making mapping Japanese RWD to the CDM challenging. In addition, the wide variety of pharmaceutical products in Japan has hindered the establishment of mappings to RxNorm, the standardized drug terminology used in OHDSI. Previously, we used a Large Language Model (LLM) to map Japanese pharmaceutical data to RxNorm. A sampling-based evaluation confirmed that the LLM could accurately identify mapping candidates. Pharmacists and a medical informatics researcher validated these mappings, resulting in an ingredient-based mapping of Japanese pharmaceutical terms to RxNorm. Researchers interested in pharmacoepidemiology, pharmacoeconomics, and drug-related clinical decision support systems integrated with Japanese RWD can benefit significantly from this dataset. It also contains information about the target drugs, their translated names, LLM-generated suggestions, and reference data, making it suitable for developing and validating natural language processing and machine learning techniques for terminology mapping.

Authors

Institutions

Publication Details

Journal
Data in Brief
Published
2025-02-21
DOI
https://doi.org/10.1016/j.dib.2025.111418
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A dataset for mapping the Japanese drugs to RxNorm standard concepts

Eizen Kimura, Yukinobu Kawakami, Shingo Inoue, Ai Okajima
Data in Brief
Computational Drug Discovery Methods
article

A dataset for mapping the Japanese drugs to RxNorm standard concepts

Eizen Kimura, Yukinobu Kawakami, Shingo Inoue, Ai Okajima
article en

Abstract

Observational Health Data Sciences and Informatics (OHDSI) is an international research community dedicated to large-scale observational studies using real-world healthcare data. Participation in OHDSI requires mapping local terminology systems to the OHDSI Standard Vocabulary (OSV) and transforming healthcare data into the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM), a standardized database schema. Adherence to the OSV and CDM enables the integration of datasets from different countries and regions, facilitating international cross-sectional analyses and supporting the discovery of large-scale evidence and new medical knowledge. Despite the globally recognized healthcare technology and systems excellence in Japan, Japanese real-world data (RWD) remain underutilized in international research. This is primarily due to reliance on domestically managed controlled terminologies in Japan that are not aligned with international controlled terminologies such as SNOMED CT, making mapping Japanese RWD to the CDM challenging. In addition, the wide variety of pharmaceutical products in Japan has hindered the establishment of mappings to RxNorm, the standardized drug terminology used in OHDSI. Previously, we used a Large Language Model (LLM) to map Japanese pharmaceutical data to RxNorm. A sampling-based evaluation confirmed that the LLM could accurately identify mapping candidates. Pharmacists and a medical informatics researcher validated these mappings, resulting in an ingredient-based mapping of Japanese pharmaceutical terms to RxNorm. Researchers interested in pharmacoepidemiology, pharmacoeconomics, and drug-related clinical decision support systems integrated with Japanese RWD can benefit significantly from this dataset. It also contains information about the target drugs, their translated names, LLM-generated suggestions, and reference data, making it suitable for developing and validating natural language processing and machine learning techniques for terminology mapping.

Data in BriefVol. 59
Tokyo University of Information Sciences (JP), Ehime Medical Center (JP), Ehime University (JP)
Ministry of Education, Culture, Sports, Science and Technology
Openalex Percentile: Top 96%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.